Genomics England and Partners to Sequence 35K COVID-19 Patients to Look for Genetic Links...
The study initially aims to enroll 20,000 people who are currently, or were previously, in intensive care with severe COVID-19 disease, as well as 15,000 infected individuals who suffered only mild or moderate symptoms.
Genebass Browser Launched to Help Improve Genetic Disease Identification
New browser tool Genebass allows researchers and clinicians to search for rare genetic variants linked to diseases.
Orna Scores Merck Collaboration and $221M Series B
Merck and Orna Therapeutics signed a collaboration agreement to discover, develop, and commercialize multiple programs around Orna's novel circular RNA (oRNA) technology.
Hormone Inhibits Liver Tumor Growth in Mice
University of Michigan (U-M) Life Sciences Institute scientists have discovered a hormone secreted by fat cells can prevent the growth of liver tumors in mice.
Inhibitor of RET Receptor Tyrosine Kinase Shows Promise Against Multiple Cancers
Precision oncology therapy pralsetinib achieved a disease control rate of 83% and an overall response rate of 57% in a Phase I/II trial.
Mount Sinai and Regeneron Launch Massive Sequencing Project
The Mount Sinai Million Health Discoveries Program has just been launched by Mount Sinai Health System with the Regeneron Genetics Center. The program aims to enroll one million Mount Sinai patients over a five-year period.
